Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 6, 2024; 12(25): 5653-5656
Published online Sep 6, 2024. doi: 10.12998/wjcc.v12.i25.5653
Clear cell sarcoma of the pancreas, an unusual cancer with unusual metastatic site or unusual primary site?
Jhenyffer Carvalho Moreno, Pedro Luiz Serrano Uson Junior
Jhenyffer Carvalho Moreno, Universidade 9 de Julho, Sao Paulo 01509120, Brazil
Pedro Luiz Serrano Uson Junior, Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil
Pedro Luiz Serrano Uson Junior, Department of Oncology, Hospital do Coração, Sao Paulo 04004030, Brazil
Author contributions: Moreno JC and Uson Junior PLS wrote the article, reviewed and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Pedro Luiz Serrano Uson Junior, MD, Academic Editor, Academic Research, Assistant Professor, Teacher, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, São Paulo 05652-900, Brazil. pedro.serrano@einstein.br
Received: March 20, 2024
Revised: April 29, 2024
Accepted: May 17, 2024
Published online: September 6, 2024
Processing time: 118 Days and 11.7 Hours
Core Tip

Core Tip: Clear cell sarcoma is a rare type of malignant tumor that can arise from tendons and aponeuroses. However, different primary sites including gastrointestinal organs are also described. Next generating sequencing evaluation can help identify molecular biomarkers that can help with the diagnosis and treatment. Although surgical resection is the mainstream treatment for most patients, the recurrence of the disease is common and normally is refractory to standard treatments including chemotherapy.